Sally Chappell

1.3k total citations
24 papers, 623 citations indexed

About

Sally Chappell is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cancer Research. According to data from OpenAlex, Sally Chappell has authored 24 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 6 papers in Cancer Research. Recurrent topics in Sally Chappell's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Pregnancy and preeclampsia studies (4 papers) and Alzheimer's disease research and treatments (4 papers). Sally Chappell is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Pregnancy and preeclampsia studies (4 papers) and Alzheimer's disease research and treatments (4 papers). Sally Chappell collaborates with scholars based in United Kingdom, Italy and Ireland. Sally Chappell's co-authors include Linda Morgan, Kevin Morgan, Noor Kalsheker, Tamar Guetta‐Baranes, C. M. O’Connor, Seamas C. Donnelly, William MacNee, Ann Millar, Roberto Rabinovich and Josep Roca and has published in prestigious journals such as PLoS ONE, Hepatology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Sally Chappell

23 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Chappell United Kingdom 12 175 138 135 134 115 24 623
Robert Wellings United Kingdom 13 217 1.2× 103 0.7× 71 0.5× 307 2.3× 43 0.4× 21 531
Jong Yun Hwang South Korea 14 44 0.3× 178 1.3× 213 1.6× 63 0.5× 128 1.1× 44 603
Carlos Menendez‐Castro Germany 17 72 0.4× 155 1.1× 184 1.4× 39 0.3× 240 2.1× 37 584
Darijana Horvat United States 15 54 0.3× 172 1.2× 261 1.9× 64 0.5× 161 1.4× 27 581
Mariko Hida Japan 14 108 0.6× 440 3.2× 56 0.4× 55 0.4× 110 1.0× 41 834
Yiding Bian China 12 52 0.3× 135 1.0× 60 0.4× 41 0.3× 49 0.4× 19 322
Damien C. Croteau‐Chonka United States 14 106 0.6× 278 2.0× 31 0.2× 261 1.9× 54 0.5× 25 755
Hongbo Qi China 17 48 0.3× 256 1.9× 375 2.8× 40 0.3× 201 1.7× 55 708
Akiyo Sekimoto Japan 16 37 0.2× 160 1.2× 179 1.3× 47 0.4× 161 1.4× 33 618
Eva Gerdin Sweden 15 102 0.6× 143 1.0× 103 0.8× 20 0.1× 127 1.1× 24 796

Countries citing papers authored by Sally Chappell

Since Specialization
Citations

This map shows the geographic impact of Sally Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Chappell more than expected).

Fields of papers citing papers by Sally Chappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Chappell. The network helps show where Sally Chappell may publish in the future.

Co-authorship network of co-authors of Sally Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Chappell. A scholar is included among the top collaborators of Sally Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Chappell. Sally Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McClure, C. Patrick, Alexander W. Tarr, Sally Chappell, et al.. (2022). Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection. Journal of Medical Virology. 95(1). e28331–e28331. 3 indexed citations
2.
Chappell, Sally, Tulsi Patel, Tamar Guetta‐Baranes, et al.. (2018). Observations of extensive gene expression differences in the cerebellum and potential relevance to Alzheimer’s disease. BMC Research Notes. 11(1). 646–646. 17 indexed citations
3.
Barber, Imelda, Tulsi Patel, Tamar Guetta‐Baranes, et al.. (2017). Methylation Profiling RIN3 and MEF2C Identifies Epigenetic Marks Associated with Sporadic Early Onset Alzheimer’s Disease. Journal of Alzheimer s Disease Reports. 1(1). 97–108. 16 indexed citations
4.
Wain, Louise V., Linda Odenthal-Hesse, Ian Sayers, et al.. (2014). Copy Number Variation of the Beta-Defensin Genes in Europeans: No Supporting Evidence for Association with Lung Function, Chronic Obstructive Pulmonary Disease or Asthma. PLoS ONE. 9(1). e84192–e84192. 11 indexed citations
5.
Chappell, Sally, Leslie Daly, Tamar Guetta‐Baranes, et al.. (2011). The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study. BMC Medical Genetics. 12(1). 24–24. 39 indexed citations
6.
Chappell, Sally. (2010). Human Genetics 2nd Edition. PubMed Central. 1(2). 166–166.
7.
Haq, Imran Ul, Sally Chappell, Simon R. Johnson, et al.. (2010). Association of MMP - 12 polymorphisms with severe and very severe COPD: A case control study of MMPs - 1, 9 and 12in a European population. BMC Medical Genetics. 11(1). 7–7. 69 indexed citations
8.
Chappell, Sally, Leslie Daly, Kevin Morgan, et al.. (2008). Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. European Respiratory Journal. 32(4). 931–937. 28 indexed citations
9.
Morgan, Kevin, Sally Chappell, Tamar Guetta‐Baranes, Stephen R. Morley, & Noor Kalsheker. (2008). The alpha-1-antitrypsin gene promoter in human A549 lung derived cells, and a novel transcription initiation site. The International Journal of Biochemistry & Cell Biology. 41(5). 1157–1164. 6 indexed citations
10.
Kalsheker, Noor & Sally Chappell. (2008). The New Genetics and Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 5(4). 257–264. 6 indexed citations
11.
Belbin, Olivia, J L Dunn, Linda Morgan, et al.. (2007). Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease. Human Molecular Genetics. 16(18). 2199–2208. 45 indexed citations
12.
Chappell, Sally, Nedim Hadžić, Robert A. Stockley, et al.. (2007). A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease. Hepatology. 47(1). 127–132. 39 indexed citations
13.
Porcellini, Elisa, Elena Calabrese, Franca Rosa Guerini, et al.. (2007). The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration. Neuroscience Letters. 416(1). 66–70. 23 indexed citations
14.
Tower, Clare, et al.. (2006). Altered transmission of maternal angiotensin II receptor haplotypes in fetal growth restriction. Human Mutation. 27(2). 138–144. 6 indexed citations
15.
Tower, Clare, Sally Chappell, Noor Kalsheker, Philip N. Baker, & Linda Morgan. (2006). Angiotensinogen gene variants and small‐for‐gestational‐age infants. BJOG An International Journal of Obstetrics & Gynaecology. 113(3). 335–339. 1 indexed citations
16.
Plant, Barry J., Charles G. Gallagher, Richard Bucala, et al.. (2005). Cystic Fibrosis, Disease Severity, and a Macrophage Migration Inhibitory Factor Polymorphism. American Journal of Respiratory and Critical Care Medicine. 172(11). 1412–1415. 75 indexed citations
17.
Nielsen, Henrietta M., Lennart Minthon, H.T. Wright, et al.. (2005). Effects of Alzheimer's peptide and α1-antichymotrypsin on astrocyte gene expression. Neurobiology of Aging. 28(1). 51–61. 10 indexed citations
18.
Chappell, Sally, Leslie Daly, Kevin Morgan, et al.. (2005). Cryptic haplotypes ofSERPINA1confer susceptibility to chronic obstructive pulmonary disease. Human Mutation. 27(1). 103–109. 47 indexed citations
19.
Tower, Clare, Sally Chappell, Kevin Morgan, et al.. (2005). Transforming growth factor β1 regulates angiotensin II type I receptor gene expression in the extravillous trophoblast cell line SGHPL-4. Molecular Human Reproduction. 11(12). 847–852. 5 indexed citations
20.
Chappell, Sally, Tamar Guetta‐Baranes, Kevin Morgan, et al.. (2004). Haplotypes of the alpha-1 antitrypsin gene in healthy controls and Z deficiency patients. Human Mutation. 24(6). 535–536. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Wellings Breakdown of academic impact, for papers by Jong Yun Hwang Breakdown of academic impact, for papers by Carlos Menendez‐Castro Breakdown of academic impact, for papers by Darijana Horvat Breakdown of academic impact, for papers by Mariko Hida Breakdown of academic impact, for papers by Yiding Bian Breakdown of academic impact, for papers by Damien C. Croteau‐Chonka Breakdown of academic impact, for papers by Hongbo Qi Breakdown of academic impact, for papers by Akiyo Sekimoto Breakdown of academic impact, for papers by Eva Gerdin
Rankless by CCL
2026